B-029-2

N/A

Report date: 2022/01/05 15:24:33
NME

Base Information

Drug NameB-029-2
Drug Alias NameB-029-2
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone acetyltransferase p300 inhibitorscAMP-response element binding protein inhibitors
TargetsHistone acetyltransferase p300cAMP-response element binding protein
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Oriental Hospital
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Oriental Hospital
Inactive CompaniesN/A
Active IndicationsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A